APA (7th ed.) Citation

K, O., C, X., S, P., M, T., T, T., H, H., . . . A, G. (2023). Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma. Biomedicines, 11(1), . https://doi.org/10.3390/biomedicines11010119

Chicago Style (17th ed.) Citation

K, Okuno, Xu C, Pascual-Sabater S, Tokunaga M, Takayama T, Han H, Fillat C, Kinugasa Y, and Goel A. "Andrographis Reverses Gemcitabine Resistance Through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma." Biomedicines 11, no. 1 (2023). https://doi.org/10.3390/biomedicines11010119.

MLA (9th ed.) Citation

K, Okuno, et al. "Andrographis Reverses Gemcitabine Resistance Through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma." Biomedicines, vol. 11, no. 1, 2023, https://doi.org/10.3390/biomedicines11010119.